Sai Rangarao - 02 Jul 2025 Form 4 Insider Report for Pelthos Therapeutics Inc. (CHRO)

Role
Chief Commercial Officer
Signature
/s/ Sai Rangarao
Issuer symbol
CHRO
Transactions as of
02 Jul 2025
Net transactions value
$0
Form type
4
Filing time
21 Jul 2025, 20:26:43 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rangarao Sai Chief Commercial Officer C/O PELTHOS THERAPEUTICS INC., 4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM /s/ Sai Rangarao 21 Jul 2025 0002077227

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTHS Restricted Stock Units Award +30,518 30,518 02 Jul 2025 Common Stock 30,518 $13.50 Direct F1
transaction PTHS Stock Option Award +93,000 93,000 02 Jul 2025 Common Stock 93,000 $13.50 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 2, 2025, the Reporting Person was granted restricted stock units to purchase 30,518 shares of common stock at an exercise price of $13.50 per share, with the initial one third (1/3) of such shares vesting on July 2, 2026, and in equal installments on a quarterly basis thereafter over a period of two (2) years.
F2 On July 2, 2025, the Reporting Person was granted stock options to purchase 93,000 shares of common stock at an exercise price of $13.50 per share, with the initial one third (1/3) of such shares vesting on July 2, 2026, and in equal installments on a quarterly basis thereafter over a period of two (2) years.